IBEX LTD (IBEX)
BMG4690M1010 - Common Stock
We assign a fundamental rating of 6 out of 10 to IBEX. IBEX was compared to 83 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. IBEX may be a bit undervalued, certainly considering the very reasonable score on growth This makes IBEX very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
In the past 5 years IBEX has always been profitable.
In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
IBEX's Return On Assets of 11.02% is amongst the best of the industry. IBEX outperforms 86.42% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, IBEX belongs to the top of the industry, outperforming 82.72% of the companies in the same industry.
The Return On Invested Capital of IBEX (15.15%) is better than 91.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.02% | ||
| ROE | 19.73% | ||
| ROIC | 15.15% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 6.57%, IBEX is doing good in the industry, outperforming 69.14% of the companies in the same industry.
IBEX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 8.39%, IBEX is in the better half of the industry, outperforming 67.90% of the companies in the same industry.
In the last couple of years the Operating Margin of IBEX has grown nicely.
IBEX has a Gross Margin (30.23%) which is in line with its industry peers.
In the last couple of years the Gross Margin of IBEX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.39% | ||
| PM (TTM) | 6.57% | ||
| GM | 30.23% |
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IBEX is creating some value.
There is no outstanding debt for IBEX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
IBEX has an Altman-Z score of 4.05. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.05, IBEX is doing good in the industry, outperforming 64.20% of the companies in the same industry.
The Debt to FCF ratio of IBEX is 0.06, which is an excellent value as it means it would take IBEX, only 0.06 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of IBEX (0.06) is better than 91.36% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that IBEX is not too dependend on debt financing.
IBEX has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. IBEX outperforms 85.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Altman-Z | 4.05 |
ROIC/WACC1.26
WACC12.02%
2.3 Liquidity
A Current Ratio of 2.42 indicates that IBEX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.42, IBEX is in the better half of the industry, outperforming 75.31% of the companies in the same industry.
A Quick Ratio of 2.42 indicates that IBEX has no problem at all paying its short term obligations.
The Quick ratio of IBEX (2.42) is better than 75.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.42 | ||
| Quick Ratio | 2.42 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 15.46% over the past year.
The Earnings Per Share has been growing by 25.59% on average over the past years. This is a very strong growth
IBEX shows a decrease in Revenue. In the last year, the revenue decreased by -1.20%.
The Revenue has been growing slightly by 6.66% on average over the past years.
EPS 1Y (TTM)15.46%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%30%
Revenue 1Y (TTM)-1.2%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%4.1%
3.2 Future
Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.13% on average per year.
Based on estimates for the next years, IBEX will show a small growth in Revenue. The Revenue will grow by 3.80% on average per year.
EPS Next Y15.95%
EPS Next 2Y13.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.3%
Revenue Next 2Y3.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.05, the valuation of IBEX can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 93.83% of the companies listed in the same industry.
IBEX is valuated cheaply when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.47, the valuation of IBEX can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 95.06% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. IBEX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.05 | ||
| Fwd PE | 7.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IBEX is valued cheaper than 92.59% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IBEX is valued cheaply inside the industry as 82.72% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.85 | ||
| EV/EBITDA | 4.44 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBEX has a very decent profitability rating, which may justify a higher PE ratio.
IBEX's earnings are expected to grow with 13.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)0.35
EPS Next 2Y13.13%
EPS Next 3YN/A
5. Dividend
5.1 Amount
IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IBEX LTD
NASDAQ:IBEX (12/20/2024, 8:17:39 PM)
After market: 20.278 0 (-0.01%)20.28
+0.26 (+1.3%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners73.77%
Inst Owner Change1.83%
Ins Owners17.87%
Ins Owner Change-126.66%
Market Cap339.89M
Analysts82.5
Price Target23.97 (18.2%)
Short Float %1%
Short Ratio1.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.82%
Min EPS beat(2)7.33%
Max EPS beat(2)8.31%
EPS beat(4)3
Avg EPS beat(4)8.33%
Min EPS beat(4)-14.31%
Max EPS beat(4)31.98%
EPS beat(8)6
Avg EPS beat(8)13.47%
EPS beat(12)8
Avg EPS beat(12)12.12%
EPS beat(16)11
Avg EPS beat(16)13.1%
Revenue beat(2)1
Avg Revenue beat(2)0.72%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)1.58%
Revenue beat(4)1
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.62%
Max Revenue beat(4)1.58%
Revenue beat(8)1
Avg Revenue beat(8)-2.86%
Revenue beat(12)3
Avg Revenue beat(12)-1.62%
Revenue beat(16)3
Avg Revenue beat(16)-2.07%
PT rev (1m)9.3%
PT rev (3m)23.68%
EPS NQ rev (1m)4.12%
EPS NQ rev (3m)17.44%
EPS NY rev (1m)5.24%
EPS NY rev (3m)11.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.05 | ||
| Fwd PE | 7.47 | ||
| P/S | 0.66 | ||
| P/FCF | 13.85 | ||
| P/OCF | 9.72 | ||
| P/B | 1.99 | ||
| P/tB | 2.13 | ||
| EV/EBITDA | 4.44 |
EPS(TTM)2.24
EY11.05%
EPS(NY)2.71
Fwd EY13.38%
FCF(TTM)1.46
FCFY7.22%
OCF(TTM)2.09
OCFY10.29%
SpS30.65
BVpS10.21
TBVpS9.5
PEG (NY)0.57
PEG (5Y)0.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.02% | ||
| ROE | 19.73% | ||
| ROCE | 18.87% | ||
| ROIC | 15.15% | ||
| ROICexc | 20.83% | ||
| ROICexgc | 22.42% | ||
| OM | 8.39% | ||
| PM (TTM) | 6.57% | ||
| GM | 30.23% | ||
| FCFM | 4.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.68
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.06 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 55.53% | ||
| Cap/Sales | 2.03% | ||
| Interest Coverage | 74.86 | ||
| Cash Conversion | 56.5% | ||
| Profit Quality | 72.71% | ||
| Current Ratio | 2.42 | ||
| Quick Ratio | 2.42 | ||
| Altman-Z | 4.05 |
F-Score6
WACC12.02%
ROIC/WACC1.26
Cap/Depr(3y)96.17%
Cap/Depr(5y)91.5%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.32%
Profit Quality(3y)72.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.46%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%30%
EPS Next Y15.95%
EPS Next 2Y13.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.2%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%4.1%
Revenue Next Year3.3%
Revenue Next 2Y3.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.83%
EBIT growth 3Y35.57%
EBIT growth 5Y44.18%
EBIT Next Year83.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y69.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.54%
OCF growth 3Y30.7%
OCF growth 5Y74.8%